Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NovaDel Pharma makes appointment

This article was originally published in Scrip

Executive Summary

NovaDel Pharma (US) has appointed Craig Johnson senior vice-president, chief financial officer and secretary. The company's chairman, president and chief executive officer, Steven Ratoff, had been serving interim CFO and secretary since April 2009. Mr Johnson served as vice-president and CFO of TorreyPines Therapeutics from 2004 until its sale to Raptor Pharmaceutical in September 2009. Following the sale, he was vice-president of TPTX, a subsidiary of Raptor, until April this year. NovaDel is a speciality pharmaceutical company developing oral spray formulations for a range of marketed drugs.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts